Brocklehurst J C, Dillane J B, Fry J, Armitage P
Br Med J. 1969 Apr 26;2(5651):216-8. doi: 10.1136/bmj.2.5651.216.
A double-blind cross-over trial of emepronium bromide (Cetiprin) in nocturnal frequency of micturition in a group of elderly women living in their homes showed that the drug was superior to placebo in diminishing urinary frequency, though not every person benefited. It is suggested that the drug may alter the established habit of rising at night to pass urine. Side-effects were negligible.
对一组居家老年女性进行的溴美喷酯(西替普林)治疗夜间尿频的双盲交叉试验表明,该药物在减少尿频方面优于安慰剂,尽管并非每个人都从中受益。有人认为该药物可能会改变夜间起床排尿的既定习惯。副作用可忽略不计。